Barclays’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $880 | Sell |
506
-216
| -30% | -$356 | ﹤0.01% | 4904 |
|
|
2025
Q4 | $1.26K | Buy |
722
+721
| +72,100% | +$1.59K | ﹤0.01% | 5076 |
|
|
2025
Q3 | $2 | Sell |
1
-81
| -99% | -$155 | ﹤0.01% | 5433 |
|
|
2025
Q2 | $167 | Sell |
82
-36,327
| -100% | -$69.6K | ﹤0.01% | 5095 |
|
|
2025
Q1 | $59.3K | Sell |
36,409
-2,705
| -7% | -$5.43K | ﹤0.01% | 4575 |
|
|
2024
Q4 | $71.6K | Buy |
39,114
+5,111
| +15% | +$22.6K | ﹤0.01% | 4665 |
|
|
2024
Q3 | $197K | Buy |
34,003
+25,116
| +283% | +$207K | ﹤0.01% | 4310 |
|
|
2024
Q2 | $71.8K | Buy |
+8,887
| New | +$93.5K | ﹤0.01% | 4062 |
|
|
2023
Q3 | – | Sell |
-5,393
| Closed | -$28.9K | – | 4647 |
|
|
2023
Q2 | $28.9K | Sell |
5,393
-66,172
| -92% | -$533K | ﹤0.01% | 4051 |
|
|
2023
Q1 | $704K | Sell |
71,565
-41,236
| -37% | -$703K | ﹤0.01% | 3002 |
|
|
2022
Q4 | $2.11M | Buy |
112,801
+16,428
| +17% | +$372K | ﹤0.01% | 2229 |
|
|
2022
Q3 | $2M | Buy |
96,373
+95,454
| +10,387% | +$2.44M | ﹤0.01% | 1749 |
|
|
2022
Q2 | $19K | Sell |
919
-2,030
| -69% | -$57.2K | ﹤0.01% | 4423 |
|
|
2022
Q1 | $126K | Sell |
2,949
-17,965
| -86% | -$809K | ﹤0.01% | 3685 |
|
|
2021
Q4 | $1.25M | Buy |
20,914
+13,806
| +194% | +$1.11M | ﹤0.01% | 2681 |
|
|
2021
Q3 | $611K | Buy |
7,108
+3,686
| +108% | +$370K | ﹤0.01% | 3079 |
|
|
2021
Q2 | $380K | Sell |
3,422
-9,580
| -74% | -$920K | ﹤0.01% | 3232 |
|
|
2021
Q1 | $1.45M | Sell |
13,002
-3,921
| -23% | -$516K | ﹤0.01% | 2536 |
|
|
2020
Q4 | $1.8M | Sell |
16,923
-3,834
| -18% | -$510K | ﹤0.01% | 2311 |
|
|
2020
Q3 | $2.89M | Sell |
20,757
-941
| -4% | -$196K | ﹤0.01% | 1797 |
|
|
2020
Q2 | $7.02M | Buy |
21,698
+5,612
| +35% | +$901K | 0.01% | 1151 |
|
|
2020
Q1 | $1.44M | Buy |
16,086
+8,354
| +108% | +$515K | ﹤0.01% | 2591 |
|
|
2019
Q4 | $306K | Buy |
7,732
+2,915
| +61% | +$87.7K | ﹤0.01% | 4707 |
|
|
2019
Q3 | $119K | Sell |
4,817
-637
| -12% | -$19.4K | ﹤0.01% | 5351 |
|
|
2019
Q2 | $192K | Buy |
5,454
+3,407
| +166% | +$135K | ﹤0.01% | 5143 |
|
|
2019
Q1 | $92K | Sell |
2,047
-3,910
| -66% | -$197K | ﹤0.01% | 5422 |
|
|
2018
Q4 | $286K | Sell |
5,957
-468
| -7% | -$28.4K | ﹤0.01% | 4324 |
|
|
2018
Q3 | $429K | Buy |
6,425
+5,527
| +615% | +$308K | ﹤0.01% | 4402 |
|
|
2018
Q2 | $42K | Sell |
898
-1,313
| -59% | -$72.4K | ﹤0.01% | 5740 |
|
|
2018
Q1 | $125K | Sell |
2,211
-4,378
| -66% | -$237K | ﹤0.01% | 5222 |
|
|
2017
Q4 | $326K | Buy |
6,589
+4,837
| +276% | +$300K | ﹤0.01% | 4262 |
|
|
2017
Q3 | $134K | Buy |
1,752
+19
| +1% | +$1.41K | ﹤0.01% | 4724 |
|
|
2017
Q2 | $163K | Buy |
1,733
+1,504
| +657% | +$129K | ﹤0.01% | 4534 |
|
|
2017
Q1 | $18K | Sell |
229
-271
| -54% | -$21.6K | ﹤0.01% | 5845 |
|
|
2016
Q4 | $42K | Sell |
500
-924
| -65% | -$83.5K | ﹤0.01% | 5274 |
|
|
2016
Q3 | $160K | Buy |
1,424
+1,409
| +9,393% | +$156K | ﹤0.01% | 4150 |
|
|
2016
Q2 | $2K | Sell |
15
-412
| -96% | -$50.1K | ﹤0.01% | 5955 |
|
|
2016
Q1 | $41K | Buy |
427
+346
| +427% | +$26.7K | ﹤0.01% | 4885 |
|
|
2015
Q4 | $5K | Sell |
81
-4,854
| -98% | -$386K | ﹤0.01% | 5568 |
|
|
2015
Q3 | $298K | Buy |
4,935
+4,814
| +3,979% | +$419K | ﹤0.01% | 3805 |
|
|
2015
Q2 | $12K | Sell |
121
-203
| -63% | -$21.7K | ﹤0.01% | 6000 |
|
|
2015
Q1 | $31K | Sell |
324
-142
| -30% | -$13.8K | ﹤0.01% | 5601 |
|
|
2014
Q4 | $50K | Sell |
466
-133
| -22% | -$16.3K | ﹤0.01% | 5714 |
|
|
2014
Q3 | $65K | Buy |
599
+481
| +408% | +$59.9K | ﹤0.01% | 5657 |
|
|
2014
Q2 | $14K | Sell |
118
-106
| -47% | -$12.5K | ﹤0.01% | 6663 |
|
|
2014
Q1 | $33K | Sell |
224
-306
| -58% | -$43.9K | ﹤0.01% | 6303 |
|
|
2013
Q4 | $51K | Buy |
+530
| New | +$53K | ﹤0.01% | 6169 |
|
Other funds holding INO
VCM
BCM
ACM
EP
